Anna Płachcińska Selected Research

EDDA (NiEDDA)

9/2006	Differential diagnosis of solitary pulmonary nodules based on 99mTc-EDDA/HYNIC-TOC scintigraphy: the effect of tumour size on the optimal method of image assessment.
2/2006	Short communication: Semiquantitative assessment of 99mTc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules--a complementary role to visual analysis.
1/2006	Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules.
10/2004	Efficacy of 99mTc-EDDA/HYNIC-TOC scintigraphy in differential diagnosis of solitary pulmonary nodules.
7/2004	99mTc-EDDA/HYNIC-TOC scintigraphy in the differential diagnosis of solitary pulmonary nodules.
1/2004	A visual and semi-quantitative assessment of (99m)Tc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Płachcińska Research Topics

Disease

6	Solitary Pulmonary Nodule 09/2006 - 01/2004
5	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 08/2008
3	Melanoma (Melanoma, Malignant) 01/2010 - 10/2003
3	Neoplasm Metastasis (Metastasis) 01/2010 - 10/2003
2	Myocardial Infarction 01/2019 - 01/2003
2	Fibrosis (Cirrhosis) 01/2017 - 01/2015
2	Cicatrix (Scar) 04/2015 - 01/2010
1	Ischemia 08/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2019
1	Shock 01/2017
1	Dent disease 1 01/2015
1	Essential Hypertension 01/2015
1	Abdominal Injuries 01/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Sarcoidosis (Schaumann Disease) 01/2012
1	ST Elevation Myocardial Infarction 04/2009
1	Neoplasms (Cancer) 02/2006
1	Atherosclerosis 01/2006
1	Prostatic Neoplasms (Prostate Cancer) 10/2003
1	Leiomyosarcoma 10/2003
1	Carcinoid Tumor (Carcinoid) 10/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2003

Drug/Important Bio-Agent (IBA)

6	EDDA (NiEDDA)IBA 09/2006 - 01/2004
5	RadiopharmaceuticalsIBA 01/2010 - 01/2006
4	Radioisotopes (Radionuclides)IBA 11/2021 - 01/2003
2	benzamideIBA 01/2010 - 01/2008
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2004 - 07/2004
1	CdZnTeIBA 11/2021
1	Technetium (Technetium 99m)IBA 08/2021
1	Pharmaceutical PreparationsIBA 01/2019
1	F 4 (F-4)IBA 01/2017
1	Succimer (Dimercaptosuccinic Acid)FDA Link 04/2015
1	Technetium Tc 99m Dimercaptosuccinic AcidIBA 04/2015
1	ethylene dicysteineIBA 04/2015
1	technetium 99m methoxyisobutylisonitrileIBA 05/2013
1	CalciumIBA 01/2012
1	8-epi-prostaglandin F2alphaIBA 01/2012
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	C-Reactive ProteinIBA 01/2012
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2012
1	MetalsIBA 01/2010
1	Dipyridamole (Persantine)FDA LinkGeneric 08/2008
1	Atropine FDA LinkGeneric 08/2008
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2006
1	99mTc-octreotideIBA 01/2006
1	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2003

Therapy/Procedure

2	Semiconductors 11/2021 - 08/2021
2	Gamma Cameras (Gamma Camera) 11/2021 - 11/2021
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 01/2017 - 01/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019
1	Aftercare (After-Treatment) 01/2017
1	Therapeutics 01/2016
1	Percutaneous Coronary Intervention 04/2009